Pharmacy OneSource Blog

ASHP Midyear 2016: Review Changing Antimicrobial Stewardship and Sterile Compounding Regulations

Posted on 11/29/16

ASHPMidyear15-Booth.jpg

Evolving antimicrobial stewardship and sterile compounding regulations will be some of the most popular issues covered at this year’s ASHP Midyear Conference in Las Vegas from December 4 to 8.

With increasing oversight on antimicrobial stewardship, including mandated standards from The Joint Commission and CMS, it is quickly becoming critical that every facility has a data-driven antimicrobial stewardship program (ASP) in place to minimize the impact of this growing threat to patient safety. 

Regulations in sterile compounding have also evolved over the last year with proposed regulations to USP Chapter <797> and recently published USP Chapter <800>, which tightens standards for compounding sterile preparations and hazardous medications.

Come and visit the Pharmacy OneSource team at Wolters Kluwer Booth #633 where we will be discussing how we help pharmacists identify and solve for gaps in their facility’s ASP with Sentri7 clinical surveillance. In the newly released KLAS report, Clinical Decision Support 2016, Sentri7 achieved the highest overall score in the Surveillance category, citing attentive service, stability and customizability as key differentiators for Sentri7.

Our team would also love to show you how Simplifi 797 quality assurance and training can help you to comply with the changing USP 797 and 800 standards.

We are also excited to showcase two in-booth presentations:

  • Are You Prepared to Deliver Antimicrobial Stewardship Services? Empowering Your Program with Clinical Surveillance on Monday, December 5 from 12:45-1:15PM and Tuesday, December 6 from 12:30-1:00PM. Wolters Kluwer expert clinicians will discuss how to design an antimicrobial stewardship program built on data-driven, technology-enabled workflows.
  • The Current State of Compounding Regulations with Eric S. Kastango on Monday, December 5 from 2:15-2:45PM. Eric S. Kastango will review the regulatory environment for sterile and hazardous drug compounding.

 We hope to see you there!

usp 797

Topics: Clinical Surveillance, Sterile Compounding

About the Author

Deb Oroszlan is the Marketing Director for Pharmacy OneSource - Wolters Kluwer.